Trending News

Braskem posts Recurring EBITDA of US$230 million in the quarter, 9% higher than 4Q23 and 12% higher than 1Q23

SÃO PAULO, May 9, 2024 /PRNewswire/ -- BRASKEM S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK) the largest resin producer in the Americas and the world's leading biopolymers producer, presents its 1Q24 Earnings Release. 1Q24 HIGHLIGHTS CONSOLIDATED Recurring EBITDA of US$230 million, around R$1,140 million, higher...

FinTech Global selects ION products for 2024 FinCrimeTech50 list

LONDON, May 9, 2024 /PRNewswire/ -- ION, a global leader in trading and workflow automation software, high-value analytics and insights, and strategic consulting to financial institutions, central banks, governments, and corporate organizations, announces that FinTech Global has listed three ION products in the 2024...

NICB Works With Kentucky Lawmakers to Protect Consumers from Auto Glass Fraud

New Law Curbs Fraudulent Activities and Ensures Transparency in Auto Glass Repair Process FRANKFORT, Ky., May 8, 2024 /PRNewswire/ -- In response to rising concerns about auto glass repair fraud in the Bluegrass State, the National Insurance Crime Bureau (NICB), the nation's premier non-profit association dedicated...

Dive Deeper News Reviews

Best Roth IRA Investments and IRA Investment Ideas

Best Roth IRA Investments and IRA Investment Ideas An IRA is beneficial for many reasons, including letting you save money ahead of retirement with tax-free growth. This article will discuss the different Roth IRA Investments and the best Roth IRA investments and investment options for you. But before we jump into great IRA investment ideas and how much you can contribute to a Roth IRA, let's...

Latest Reviews

More Reviews

More Industry News

Head-to-head Superiority to High-dose Dulaglutide: Innovent's First Phase 3 Clinical Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints

SAN FRANCISCO and SUZHOU, China, May 8, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, announces that the Phase 3 clinical trial (DREAMS-2) of mazdutide (Innovent R&D code: IBI362), a glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR) dual...

More Industry News

Videos

WeeklyReviewer - Industry News, Reviews and More! WeeklyReviewer industry news

Coronavirus Statistics

Latest Global Covid-19 Coronavirus Statistics By Country

The Covid-19 Coronavirus is a major pandemic spreading globally. This page is dedicated to providing up to date statistics on the Confirmed Cases, Confirmed Deaths, Recovered Patients, and Active Cases of Coronavirus around the world.

WeeklyReviewer News and News Reviews

WeeklyReviewer News, News Reviews and Analysis of Major News

WeeklyReviewer publishes industry news and reviews daily, engaging readers with press releases, news and reviews across major industries and sectors. Read our Dive Deeper News Reviews for more thorough analysis on major debates and conversations.

WeeklyReviewer - Industry News, Reviews and More! WeeklyReviewer industry news